Skip to content

HLG: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

HLG

BE 0697.858.283
NACE 86.220, Specialist medical practice
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-
not filed
Equity
€18,600
2024 · €18,600
Cash
€195,990
2024 · €128,008+€67,982
Balance sheet total
€5.7m
2024 · €5.2m+€460,231

Largest movements

2024 to 2025
Assets
  • Deferred charges and accrued income +€398,995

    up €398,995 (+8.0%), from €5.0m to €5.4m

  • Cash +€67,982

    up €67,982 (+53.1%), from €128,008 to €195,990

Equity and liabilities
  • Accrued charges and deferred income +€458,033

    up €458,033 (+8.9%), from €5.2m to €5.6m

Income statement
  • Gross operating margin +€4,298

    up €4,298 (+96.0%), from €4,477 to €8,775

  • Depreciation +€4,260

    up €4,260 (+155.5%), from €2,740 to €7,000

From the 2024 result to the 2025 result

effect on the result

The net result is not in both sets of accounts; without it the difference cannot be explained line by line.

Cash bridge derived

cash 2024 to 2025

Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.

Every line side by side 24 lines
Line Code 2024 2025 Change %
Total assets 20/58 €5,197,951 €5,658,182 +€460,231 +8.9%
Fixed assets 21/28 €67,260 €60,260 -€7,000 -10.4%
Tangible fixed assets 22/27 €67,260 €60,260 -€7,000 -10.4%
Other tangible fixed assets 26 €67,260 €60,260 -€7,000 -10.4%
Current assets 29/58 €5,130,691 €5,597,922 +€467,231 +9.1%
Amounts receivable within one year 40/41 €4,746 €5,000 +€254 +5.3%
Trade receivables 40 €4,746 €0 -€4,746 -100.0%
Other amounts receivable 41 €0 €5,000 +€5,000
Cash at bank and in hand 54/58 €128,008 €195,990 +€67,982 +53.1%
Deferred charges and accrued income 490/1 €4,997,937 €5,396,932 +€398,995 +8.0%
Total equity and liabilities 10/49 €5,197,951 €5,658,182 +€460,231 +8.9%
Equity 10/15 €18,600 €18,600 = 0.0%
Contributions 10/11 €18,600 €18,600 = 0.0%
Amounts payable 17/49 €5,179,351 €5,639,582 +€460,231 +8.9%
Amounts payable within one year 42/48 €7,122 €9,319 +€2,197 +30.9%
Trade debts 44 €7,122 €9,319 +€2,197 +30.9%
Suppliers 440/4 €7,122 €9,319 +€2,197 +30.9%
Accrued charges and deferred income 492/3 €5,172,230 €5,630,263 +€458,033 +8.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,740 €7,000 +€4,260 +155.5%
Other operating charges 640/8 €1,663 €1,637 -€26 -1.6%
Gross operating margin 9900 €4,477 €8,775 +€4,298 +96.0%
Operating profit (loss) 9901 €74 €138 +€65 +88.0%
Financial charges 65/66B €74 €138 +€65 +88.0%
Recurring financial charges 65 €74 €138 +€65 +88.0%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.